Emerging Comorbidities In Heart Failure An Issue Of Heart Failure Clinics E Book

In this issue, guest editors bring their considerable expertise to this important topic. Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.

Emerging Comorbidities in Heart Failure, An Issue of Cardiology Clinics, E-Book

This issue of Heart Failure Clinics examines co-morbidities in patients with heart failure. Topics include hypertension, diabetes, pulmonary disorders, cardiorenal syndrome, anemia, depression, atrial fibrillation, obesity and cardiac cachexia, peripheral vascular disease, rheumatologic disorders, co-morbidities and polypharmacy, coronary artery disease, and clinical trials.

This issue of Heart Failure Clinics, guest edited by Antonio Cittadini and Hector O. Ventura, will cover key topics in Emerging Comorbidities in Heart Failure. This issue is one of four selected each year by our series consulting editor, Dr. Eduardo Bossone. Topics discussed in this issue will include: Anabolic deficiencies in Heart Failure, Thyroid Abnormalities in Heart Failure, The Gut Axis Involvement in Heart Failure: focus on trimethylamine N-oxide (TMAO), Chronic Obstructive Pulmonary Disease and Heart Failure, When Pulmonary Hypertension complicates Heart Failure, Sex and Gender-related Issues in Heart Failure, Cardiac Cachexia Revisited: The Role of Wasting in Heart Failure, Atrial Fibrillation in Heart Failure, The Impact of Obesity in Heart Failure, Sleep Breathing Disorders in Heart Failure, The Cardiorenal Syndrome in Heart Failure, Psychological Disorders in Heart Failure, Hypertension in Heart Failure, among others.

This issue of Heart Failure Clinics is about acute decompensated heart failure. Expert authors review the most current information available about comorbidities, management, drug therapy, and strategies to prevent a post-discharge adverse event. Keep up-to-the-minute with the latest developments in this life-threatening disorder.

This issue of Heart Failure Clinics covers comparative-effectiveness research in heart failure. Expert authors review the most current information available about the comparative effectiveness of different treatments for heart failure, including drug treatments, cardioverter defibrillators and cardiac resynchronization therapy, as well as patient adherence. Keep up-to-the-minute with the latest developments in comparative-effectiveness research.

This important issue of Medical Clinics provides essential updates in heart failure. The following topics are covered: epidemiology, pathophysiology, and general approach for heart failure; symptoms, signs, diagnostic studies, and prognostic significance of systolic versus diastolic heart failure; the appropriate use of biomarkers; oral versus intravenous diuretic therapy; guideline-based therapy including RAAS blockade, beta-blockade, and aldosterone antagonist, appropriate use of AICD and biventricular pacing; role of ventricular assist device; pathophysiological consideration and management approaches in acute decompensated heart failure; pathophysiology and current approaches to cardiorenal syndrome; heart failure with other comorbidities including diabetes, obesity, anemia, and cancer; heart failure and atrial fibrillation; and the role of disease management strategies in heart failure.

Accounting for more than 40% of all heart failure problems, diastolic heart failure is a complex and often difficult diagnosis with rapidly evolving diagnostic management protocols. Diastology: Clinical Approach to Heart Failure with Preserved Ejection Fraction, 2nd Edition, brings you up to date and equips you to successfully diagnose and manage even the most challenging incidences of diastolic heart failure and their comorbidities. It incorporates the latest guidelines for the diagnostic evaluation of the patient with suspected or known diastolic dysfunction, provides a comprehensive review of clinical conditions associated with heart failure with preserved ejection fraction, and describes the complementary role of imaging modalities and novel therapeutic approaches. Keeps you current with recent extensive changes in the understanding of the mechanisms of diastolic heart failure with preserved ejection fraction (HFpEF) that have resulted in dramatic changes in treatment guidelines. Covers the latest molecular, genetic, and cellular mechanisms behind diastolic heart failure as a basis for the latest clinical approaches, diagnosis, and treatment of common and uncommon pathological conditions such as hypertensive heart disease, cardiomyopathies, arterial and valvular diseases, pericardial diseases, congenital heart disease, diabetes mellitus, and metabolic syndrome. Features 50 video cases, new key summary points, new multiple-choice review questions, and six new chapters: Evaluation of Diastolic Function by Radionuclide Techniques; Diastology Stress Test; ASE/EACVI Diastolic Guidelines; Valve Disease; Perioperative Assessment of Diastolic Dysfunction; and Pulmonary Hypertension. Reviews new techniques and indices for assessing diastolic function, such as 3D echo, strain rate imaging, late gadolinium enhancement and T1-mapping by CMR, and novel nuclear scintigraphic methods – as well as the traditional indices of LV filling, LA function, and tissue Doppler indices. Covers emerging topics such as the role of neurohormones, global and regional systolic function of the left ventricle, chronotopic incompetence and pacing, aging, perioperative assessment, and more. Presents information in a quick-retrieval format, covering Epidemiology, Pathophysiology, Diagnostic Evaluation, Differential Diagnosis, Treatment, and Future Directions. Helps you learn efficiently and prepare for self-assessment with key summaries and multiple-choice questions and answers for each chapter.